<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01077752</url>
  </required_header>
  <id_info>
    <org_study_id>AOR 08028</org_study_id>
    <nct_id>NCT01077752</nct_id>
  </id_info>
  <brief_title>Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia</brief_title>
  <acronym>CATCH</acronym>
  <official_title>Effect of Local Anesthetic Continuous Preperitoneal Wound Infiltration on Incisional Hyperalgesia Following Colorectal Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this multicenter, randomised, placebo-controlled, double-blind trial, hyperalgesia area
      around the scarce following colorectal laparoscopic surgery (piece removal) will be assessed
      in 3 groups of patients : group 1: continuous ropivacaine preperitoneal infusion, group 2 :
      intravenous lidocaine infusion, or group 3 : control group without local anesthetics. All
      patients will receive parenteral analgesia combining acetaminophen and morphine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Besides hyperalgesia assessment, immediate postoperative and long-term pain, morphine
      consumption, and endocrin-metabolic response will be evaluated in this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pericicatricial hyperalgesia area</measure>
    <time_frame>72 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity (rest/mobilization and long-term)</measure>
    <time_frame>72 hours, 3 months and 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>During 5 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with continuous ropivacaine preperitoneal infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with intravenous lidocaine infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients without local anesthetics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>continuous ropivacaine preperitoneal infusion</intervention_name>
    <description>Bolus of 20 mg after the surgery then 20 mg per hour during 48 hours</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous lidocaine infusion</intervention_name>
    <description>Bolus of 60 mg after the surgery then 60 mg per hour during 48 hours</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>parenteral analgesia combining acetaminophen and morphine</intervention_name>
    <description>parenteral analgesia combining acetaminophen and morphine</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl</intervention_name>
    <description>NaCl</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 80

          -  ASA status 1 - 3

          -  Colorectal laparoscopic surgery with piece removal

          -  French speaking

          -  Written informed consent

        Exclusion Criteria:

          -  laparoscopy without colorectal extraction

          -  chronic pain

          -  analgesic consumption during the 24 hours previous to the surgery

          -  morphine and LA intolerance

          -  drug addiction

          -  inflammatory bowel disease

          -  general inflammatory disease

          -  sepsis

          -  anemia &lt; 10 gr/dl

          -  liver or renal or cardiac insufficiency

          -  uncontrolled diabetes

          -  preoperative consumption of opiate/corticosteroid/beta-blockers, and anti-arrhythmic
             drugs, MAOIs, neuroleptics.

          -  preoperative consumption of NSAIDs excluding aspirin referred cardiology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Beaussier, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departement d'Anesthesie-Reanimation, Hopital Saint-Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2010</study_first_submitted>
  <study_first_submitted_qc>February 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2010</study_first_posted>
  <last_update_submitted>January 20, 2014</last_update_submitted>
  <last_update_submitted_qc>January 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain, postoperative</keyword>
  <keyword>Local infiltration</keyword>
  <keyword>Hyperalgesia, postoperative</keyword>
  <keyword>Local anesthetic, ropivacaine, lidocaine</keyword>
  <keyword>Colorectal laparoscopic surgery</keyword>
  <keyword>Pain management after colorectal laparoscopic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

